Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 27, 2026
DraftKings (DKNG): Can Shares Climb Back to $30 for a +36% Gain?

DraftKings (DKNG): Can Shares Climb Back to $30 for a +36% Gain?

Key Takeaways

  • The central question is whether DKNG can climb back to $30, a roughly 36% advance from its recent trading level near $22.
  • The strongest bullish case rests on a broadly positive analyst consensus, improving adjusted EBITDA, a $2 billion buyback authorization, and continued state-by-state market expansion.
  • The biggest obstacles are decelerating revenue growth, intensifying competition in prediction markets, persistent GAAP losses, and elevated stock volatility.
  • Key technical markers include support near the 52-week low of $20.35 and resistance around $30, followed by the $42–$44 zone that marked the 52-week high.
  • Overall, $30 appears reachable, but it likely requires a return to top-line growth and continued margin expansion rather than a simple sentiment rebound.

Why the $30 Level Matters for DraftKings

DraftKings Inc. (DKNG), a digital sports entertainment and gaming company, has seen a sharp repricing over the past year. After trading above $40 for much of 2025, the stock has slid to roughly $22, hitting a 52-week low of $20.35 in late September 2026. That decline has left investors searching for the next realistic milestone, and $30 stands out as a natural psychological target — one that also sits squarely within the range of current Wall Street price objectives.

Where DraftKings Stands Today

DraftKings operates an online sportsbook, iGaming (digital casino) products, daily fantasy sports, and a recently launched prediction-market platform. The company generated roughly $6.2 billion in trailing-twelve-month revenue, yet it remains modestly unprofitable on a generally accepted accounting principles (GAAP) basis. Its second-quarter 2026 results illustrate the tension: adjusted earnings per share (EPS) of $0.09 beat estimates, but revenue of $1.44 billion declined 4.6% year over year, and the company posted a net loss of about $67.6 million.

Still, the underlying business generates positive cash flow, and adjusted EBITDA remained in positive territory, supported by growing monthly unique payers and sports betting volume. A beta of roughly 1.75 underscores that DKNG is far more volatile than the broader market. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Bullish Drivers for a Move Higher

Several factors support a move toward $30. First, the company continues expanding into new jurisdictions, having launched sports betting in additional states and broadened its digital lottery and casino offerings. Management has also consolidated its products into a "super app," which could improve customer retention and cross-selling.

Second, capital returns provide a tailwind. DraftKings increased its share repurchase authorization to $2 billion in late 2025, a signal of confidence in future cash generation. Third, the company's adjusted EBITDA trajectory and rising monthly active payers point toward improving operating leverage as the customer base matures.

Risks That Could Hold It Back

The path to $30 is not guaranteed. The most immediate concern is slowing growth — the most recent quarter's revenue decline broke a long streak of expansion. Competition is also intensifying. DraftKings faces rivalry from FLUT (Flutter Entertainment) in sports betting and iGaming, while newer prediction-market platforms such as Kalshi are drawing scrutiny and investor attention, raising questions about customer acquisition costs and promotional spending.

Because the company remains unprofitable on a GAAP basis, any increase in marketing or technology investment could delay the earnings inflection that investors are awaiting. The stock's high beta also means broader market weakness could drag shares lower regardless of company-specific progress. From what I see, this volatility warrants close attention to both company fundamentals and broader market conditions.

Wall Street Views and Price Targets

The sell-side remains broadly constructive. The consensus rating on DKNG is generally a "Moderate Buy" or "Buy," with an average analyst price target near $34–$35 — itself above the $30 milestone in question. Individual targets range widely, from the low $20s to roughly $50 or higher, reflecting genuine disagreement about growth and profitability timing.

Notably, sentiment has cooled in recent months. Several firms lowered their targets through mid-2026, and one brokerage trimmed its objective while maintaining a "market outperform" rating, citing prediction-market competition and near-term spending pressure. A $30 target therefore sits below the Street average but well above current trading levels, framing it as a plausible intermediate objective rather than a consensus bull case.

Key Technical Levels to Watch

From a technical analysis standpoint, the $20.35 area represents an important support level — the stock's 52-week low and a zone where buyers have recently stepped in. On the upside, $30 functions as a psychological and technical resistance level, with a cluster of analyst targets between $28 and $35 reinforcing that zone. Beyond it, the $42–$44 range marks the 52-week high and the more significant supply area that must be reclaimed for any sustained recovery.

Using AI Daily Buy/Sell Signals for Monitoring

Traders monitoring volatile names like DKNG may benefit from automated tools that track shifting conditions in real time. In my own process, I’ve found Tickeron’s AI Daily Buy/Sell Signals helpful for staying on top of fast-moving names without having to watch every chart constantly. These signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. They can help investors discover new opportunities, monitor existing positions, and identify changing market trends more efficiently. I’m watching this closely as part of my routine research on names like DraftKings.

My Take on Reaching $30

Reaching $30 appears realistic but far from automatic. The strongest supports are a favorable analyst consensus, positive adjusted EBITDA, shareholder-friendly buybacks, and an expanding product ecosystem. The primary risks are decelerating revenue, rising competition, ongoing GAAP losses, and the stock's elevated volatility. For DKNG to reclaim $30, investors will likely need to see a return to revenue growth, sustained margin improvement, and clearer signs that new initiatives are translating into profitable customer expansion. As always, outcomes remain uncertain, and no price target should be treated as a certainty.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: DKNG

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


DKNG's RSI Oscillator ascending out of oversold territory

The RSI Indicator for DKNG moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 25 of the 30 cases the stock moved higher. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where DKNG advanced for three days, in 240 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

DKNG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DKNG as a result. In 66 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for DKNG turned negative on September 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

DKNG moved below its 50-day moving average on September 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DKNG crossed bearishly below the 50-day moving average on September 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DKNG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

The Aroon Indicator for DKNG entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. DKNG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: DKNG's P/B Ratio (19.194) is very high in comparison to the industry average of (4.961). DKNG has a moderately high P/E Ratio (241.778) as compared to the industry average of (75.274). Projected Growth (PEG Ratio) (0.054) is also within normal values, averaging (0.476). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (1.935) is also within normal values, averaging (1.692).

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DKNG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

Industry description

Casinos/Gaming includes companies that operate casinos, gaming services, horse racing and harness racing facilities. Think Las Vegas Sands Corp., MGM Resorts International and Wynn Resorts, Ltd. In periods of strong economic growth, consumers tend to spend on discretionary/leisure activities like gambling or games; but consumption is likely to slow down when there’s economic sluggishness.

Market Cap

The average market capitalization across the Casinos/Gaming Industry is 3.07B. The market cap for tickers in the group ranges from 3.74K to 35.21B. PDYPY holds the highest valuation in this group at 35.21B. The lowest valued company is ELYS at 3.74K.

High and low price notable news

The average weekly price growth across all stocks in the Casinos/Gaming Industry was -4%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was 1%. CDRO experienced the highest price growth at 11%, while RSI experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Casinos/Gaming Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was 73% and the average quarterly volume growth was -1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 69
Price Growth Rating: 67
SMR Rating: 75
Profit Risk Rating: 98
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
DKNG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a digital sports entertainment and gaming company, which provides online and retail sports wagering offerings, online daily fantasy contests and online casino games

Industry CasinosGaming

Industry
N/A
Address
222 Berkeley Street
Phone
+1 617 986-6744
Employees
5500
Web
https://www.draftkings.com
Interact to see
Advertisement
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Shares of GSAT are surging approximately +15% intraday on March 25, 2026, following a prior session close of $61.09. The primary catalyst is a fresh analyst note from Scotiabank highlighting Globalstar's direct-to-device satellite connectivity bypassing cellular towers — most notably in Mexico — reinforcing the company's next-generation infrastructure thesis.
Shares of ADMA are declining approximately 12% in Wednesday's session, extending a steep two-day selloff. The primary catalyst is a short-seller research report published by Culper Research on March 24, 2026, alleging that ADMA engaged in channel stuffing to artificially inflate revenue growth.
Honeywell International (HON) and TransDigm Group (TDG) are prominent players in the aerospace and industrials sector, benefiting from rising air travel demand, defense spending, and aftermarket services. This stock comparison evaluates their business models, recent performance, and market positioning to help traders and investors assess relative strengths in the current environment. With global aviation recovery and geopolitical tensions supporting sector tailwinds, professionals seeking exposure to aerospace growth versus diversified industrials stability will find these insights relevant for portfolio decisions and relative performance analysis.
PL shares are surging approximately +15% in Wednesday's session, trading near $35.89, pushing back toward the stock's 52-week high of $36.28 set on March 20, 2026. Primary catalyst: Continued momentum from a blockbuster Q4 fiscal 2026 earnings report delivered March 19, which sent revenue 41% higher year-over-year to $86.8 million, well above the $78 million Wall Street consensus.
ASTS shares surged approximately +11.00% in active intraday trading on March 25, 2026, moving from a prior close of $86.98 to approximately $96.55. The primary driver is a broad space sector rally fueled by renewed SpaceX IPO speculation, lifting satellite and space-related equities across the board.
FUBO shares are set to open about 12% lower in Wednesday’s premarket session after closing the prior day at roughly $12.02. The decline follows a strong multi-week rally powered by balance-sheet news, including the repurchase of $140.2 million of 2026 convertible notes and improving profitability trends.
One & One Green Technologies Inc. (YDDL) shares are indicated down about 13% in Wednesday’s premarket session after closing the prior regular session at $12.00. The stock had just surged 15.6% in the latest completed session, jumping from a prior close of $10.38 to $12.00, leaving it vulnerable to swift profit‑taking and volatility.
AVXL shares are indicated down about 33% in Wednesday’s premarket session, after closing the prior regular session at $4.19. The slide follows a recent drop triggered by a wider‑than‑expected fourth‑quarter loss and ongoing questions about the company’s late‑stage neurology pipeline.